Huntington National Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.2K | Buy |
756
+144
| +24% | +$5.19K | ﹤0.01% | 1461 |
|
|
2025
Q1 | $19.1K | Buy |
612
+72
| +13% | +$2.24K | ﹤0.01% | 1534 |
|
|
2024
Q4 | $13.8K | Buy |
540
+378
| +233% | +$9.64K | ﹤0.01% | 1653 |
|
|
2024
Q3 | $4.58K | Buy |
162
+10
| +7% | +$283 | ﹤0.01% | 2021 |
|
|
2024
Q2 | $4.01K | Sell |
152
-96
| -39% | -$2.53K | ﹤0.01% | 1968 |
|
|
2024
Q1 | $7.53K | Buy |
248
+73
| +42% | +$2.22K | ﹤0.01% | 1781 |
|
|
2023
Q4 | $4.92K | Sell |
175
-86
| -33% | -$2.42K | ﹤0.01% | 1896 |
|
|
2023
Q3 | $7.08K | Sell |
261
-142
| -35% | -$3.85K | ﹤0.01% | 1689 |
|
|
2023
Q2 | $12.4K | Sell |
403
-33
| -8% | -$1.01K | ﹤0.01% | 1503 |
|
|
2023
Q1 | $15.7K | Buy |
436
+175
| +67% | +$6.31K | ﹤0.01% | 1410 |
|
|
2022
Q4 | $10.3K | Sell |
261
-120
| -31% | -$4.74K | ﹤0.01% | 1481 |
|
|
2022
Q3 | $15K | Sell |
381
-644
| -63% | -$25.4K | ﹤0.01% | 1406 |
|
|
2022
Q2 | $43K | Hold |
1,025
| – | – | ﹤0.01% | 1050 |
|
|
2022
Q1 | $40K | Hold |
1,025
| – | – | ﹤0.01% | 1133 |
|
|
2021
Q4 | $41K | Buy |
+1,025
| New | +$41K | ﹤0.01% | 1138 |
|